By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Polyplus Transfection 

1251 Ave of the Americas
34th Floor
New York  New York  10020  U.S.A.
Phone: 508-315-9629 Fax: n/a



Company News
Polyplus Transfection And Blue Sky Bioservices Sign A Research And Commercial License Agreement For Use Of PEI-Based Transfection Technologies 10/29/2014 9:34:40 AM
Polyplus Transfection Launches A New Transfection Reagent For Bioproduction 5/28/2014 10:38:25 AM
Polyplus Transfection and Merck & Co., Inc. (MRK) Sign a License and Supply Agreement for PEI-Based Transfection Reagents 10/24/2013 9:34:46 AM
Polyplus Transfection Launches the Next Generation PEI Transfection Reagent for Bioproduction 1/18/2012 9:55:46 AM
Polyplus Transfection Announces the Appointment of Ten Additional Biologists and Chemists to Support Multiple Pre-Clinical Studies 9/15/2011 12:47:49 PM
Polyplus Transfection and ExcellGene Enter Into a Supply Agreement for PEI-Based Transfection Reagents 5/11/2011 11:06:03 AM
Polyplus Transfection Licenses Roche Glycart AG for PEI in Vitro Transfection Applications for Research Purposes 1/24/2011 12:26:10 PM
Polyplus Transfection Raises EUR 2.5 Million in Latest Funding Round 1/10/2011 11:07:11 AM
Polyplus Transfection Licenses Kempbio For Mammalian Transient Transfection Technology 5/18/2010 2:29:31 PM
Polyplus Transfection Appoints Mark Bloomfield AS CEO 4/30/2010 1:50:09 PM